Vapor-dispensing device

Details for Australian Patent Application No. 2003215159 (hide)

Owner The Dial Corporation

Inventors Groene, Ralf; Schmidt, Christopher Bryan; Park, Debra; He, Mengtao Pete; Triplett, Carl; Conway, Mary J.; Stathakis, Kristopher

Agent Griffith Hack

Pub. Number AU-B-2003215159

PCT Number PCT/US03/04082

PCT Pub. Number WO2003/068276

Priority 10/074,529 12.02.02 US; 10/222,079 16.08.02 US; 10/222,501 16.08.02 US

Filing date 12 February 2003

Wipo publication date 4 September 2003

Acceptance publication date 21 October 2004

International Classifications

A61L 009/03 Disinfection, sterilisation or deodorisation of air

H01R 013/443 Details of coupling devices of the kinds covered by groups or

A61L 009/12 Disinfection, sterilisation or deodorisation of air - Apparatus, e.g. holders, therefor

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 10/074,529 12.02.02 US; 10/222,079 16.08.02 US; 10/222,501 16.08.02 US

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2003215159

21 October 2004 Application Accepted

  Published as AU-B-2003215159

17 February 2005 Standard Patent Sealed

4 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003215160-NOVEL REACTION PRODUCT OF STARCHES AND AROMATIC ACIDS AND/OR AROMATIC ANHYDRIDES

2003215158-2-(5-(5-CARBAMIMIDOYL-1H-HETER OARYL))-6-HYDROXYBIPHENYL-3-YL DERIVATIVES AS FACTOR VIIA INHIBITORS